DCF — SSM HEALTH-ST. MARYS AUDRAIN
Enterprise Value: $-23.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-23.9M
Enterprise Value
$-7.4M
PV of Cash Flows
$-16.5M
PV of Terminal Value
$-26.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $10.0M | $-1.6M | -16.0% | $-2.0M | $-1.8M |
| Year 2 | $10.3M | $-1.5M | -15.0% | $-2.0M | $-1.6M |
| Year 3 | $10.6M | $-1.5M | -14.0% | $-1.9M | $-1.4M |
| Year 4 | $10.9M | $-1.5M | -13.0% | $-1.9M | $-1.3M |
| Year 5 | $11.2M | $-1.5M | -13.0% | $-1.9M | $-1.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-23.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$9.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.16339827806639007
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5